{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:08:15Z","timestamp":1760188095796,"version":"3.32.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1136\/ard.61.9.829","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T19:54:10Z","timestamp":1033502050000},"page":"829-831","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist"],"prefix":"10.1016","volume":"61","author":[{"given":"M","family":"Verdrengh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-M","family":"Jonsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O","family":"Zaether","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Bajtner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Holmdahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Tarkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.61.9.829_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-065X.1990.tb00817.x","article-title":"Type II collagen autoimmunity in animals and provocations leading to arthritis","volume":"118","author":"Holmdahl","year":"1990","journal-title":"Immunol Rev"},{"key":"10.1136\/ard.61.9.829_bib2","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/rheumatology\/31.7.433","article-title":"The synovial lining cells in chronic arthritis","volume":"31","author":"Bresnihan","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.61.9.829_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/08916939109007634","article-title":"Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA\/1 mice and spontaneous arthritis in MRL\/lpr mice","volume":"8","author":"Holmdahl","year":"1991","journal-title":"Autoimmunity"},{"key":"10.1136\/ard.61.9.829_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00918959","article-title":"Effect of irradiation, cyclophosphamide, and etoposide (VP-16) on number of peripheral blood and peritoneal leukocytes in mice under normal conditions and during acute inflammatory reaction","volume":"13","author":"van't Wout","year":"1989","journal-title":"Inflammation"},{"key":"10.1136\/ard.61.9.829_bib5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0163-4453(94)95087-3","article-title":"Influence of cytostatic agents on the pulmonary defence of mice infected with Klebsiella pneumoniae and on the efficacy of treatment with ceftriaxone","volume":"29","author":"Calame","year":"1994","journal-title":"J Infect"},{"key":"10.1136\/ard.61.9.829_bib6","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/1529-0131(200010)43:10<2276::AID-ANR15>3.0.CO;2-C","article-title":"Role of macrophages in Staphylococcus aureus-induced arthritis and sepsis","volume":"43","author":"Verdrengh","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.9.829_bib7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1002\/art.1780261011","article-title":"Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats","volume":"26","author":"Stuart","year":"1983","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.9.829_bib8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1365-2249.1998.00529.x","article-title":"B cell deficient mice do not develop type II collagen induced arthritis (CIA)","volume":"111","author":"Svensson","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.61.9.829_bib9","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1084\/jem.158.2.378","article-title":"Serum transfer of collagen induced arthritis in mice","volume":"158","author":"Stuart","year":"1983","journal-title":"J Exp Med"},{"key":"10.1136\/ard.61.9.829_bib10","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/art.1780270907","article-title":"Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen","volume":"27","author":"Wooley","year":"1984","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.9.829_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-3083.1990.tb02754.x","article-title":"Arthritis in DBA\/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies","volume":"31","author":"Holmdahl","year":"1990","journal-title":"Scand J Immunol"},{"key":"10.1136\/ard.61.9.829_bib12","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.4049\/jimmunol.141.6.1958","article-title":"Suppression of murine collagen induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN\u03b3","volume":"141","author":"Cooper","year":"1988","journal-title":"J Immunol"},{"key":"10.1136\/ard.61.9.829_bib13","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/art.1780311012","article-title":"Treatment with \u03b3 interferon triggers the onset of collagen arthritis in mice","volume":"31","author":"Mauritz","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.61.9.829_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2249.1990.tb05353.x","article-title":"The effect of treatment with interferon \u03b3 on type II collagen induced arthritis","volume":"81","author":"Nakajima","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1136\/ard.61.9.829_bib15","doi-asserted-by":"crossref","first-page":"5507","DOI":"10.4049\/jimmunol.158.11.5507","article-title":"Accelerated collagen induced arthritis in IFN\u03b3 receptor deficient mice","volume":"158","author":"Vermeire","year":"1997","journal-title":"J Immunol"},{"key":"10.1136\/ard.61.9.829_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00302149","article-title":"Double blind controlled phase III multicenter clinical trial with interferon \u03b3 in rheumatoid arthritis","volume":"12","year":"1992","journal-title":"Rheumatol Int"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724092458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724092458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.61.9.829","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T08:52:23Z","timestamp":1736067143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724092458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0003496724092458"],"URL":"https:\/\/doi.org\/10.1136\/ard.61.9.829","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2002,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Total abrogation of collagen II-induced arthritis and the B cell response to type II collagen using suboptimal doses of a topoisomerase II antagonist","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.61.9.829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 Copyright 2002 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}